Status:
RECRUITING
Evaluation of Outcomes From Treatment of Benign or Malignant Pancreatic Diseases
Lead Sponsor:
Methodist Health System
Conditions:
Benign or Malignant Pancreatic Diseases
Eligibility:
All Genders
18+ years
Brief Summary
This study will be a retrospective chart review of patients who have been diagnosed with the benign or malignant pancreatic disease under the practice of Dr. Rohan Jeyarajah, M.D., Dr. Houssam Osman M...
Detailed Description
It is reported in the literature that the treatment of any pancreatic disease process, whether benign or malignant, continues to be a huge challenge. For example, patients with adenocarcinoma continue...
Eligibility Criteria
Inclusion
- • All patients diagnosed and treated for pancreatic diseases, benign or malignant from 2005 to present
- Age ≥18 years
Exclusion
- • Patients that are not diagnosed with or treated for pancreatic diseases
- Age \< 18 years
Key Trial Info
Start Date :
March 5 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 30 2025
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04055571
Start Date
March 5 2019
End Date
January 30 2025
Last Update
March 27 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Trinity Surgical Consultants, Methodist Richardson Medical Center
Richardson, Texas, United States, 75082